Prevention of Cystoid Macular Edema After Cataract Surgery in Nondiabetic and Diabetic Patients: A Systematic Review and Meta-Analysis

This publication has 48 references indexed in Scilit:

• Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery
  Acta Ophthalmologica, 2012
• Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
  Clinical Ophthalmology, 2012
• Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site
  Clinical Ophthalmology, 2012
• Central Foveal Thickness Before and After Cataract Surgery in Normal and in Diabetic Patients without Retinopathy
  Klinische Monatsblätter für Augenheilkunde, 2012
• Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery
  Journal of Cataract & Refractive Surgery, 2011
• Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery
  Journal of Cataract & Refractive Surgery, 2011
• Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
  Journal of Ophthalmology, 2011
• Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance
  British Journal of Ophthalmology, 2009
• Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema
  Eye, 2009
• Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac
  Clinical Ophthalmology, 2009